Challenge The Trinity Challenge on Antimicrobial Resistance

How can data and analytics reduce the impact of antimicrobial resistance and bacterial infections in low- and middle-income communities?

Closed
Deadline to Submit:
uploads/65489_Trinity_AMR_Hero (2).jpg
Presented with
TTC---Linear-Logo-White-(1).png

Timeline

  • Applications Open

    November 14, 2023 9:00am EST
  • Solution Deadline

    November 14, 2023 9:00am EST
  • Reviews

    March 28, 2024 11:59pm EDT
  • First Round Judging

    April 12, 2024 1:00pm EDT
  • Second Round Judging

    May 12, 2024 11:59pm EDT
  • Winner Announcement

    June 6, 2024 12:00pm EDT

Judging Criteria

  • Potential for Impact: The planned solution implementation has the potential to impact the intended population.
  • Feasibility: The team has a realistic, practical plan for implementing the solution, it is feasible in the given context, and the team has a reasonable plan for operational sustainability and measurable results that can be proven to work.
  • Innovative Approach: The solution includes a new technology, a new application of data, digital tools and/or analytics, a new policy model, or a new process for solving the Challenge.
  • Inclusive Human-Centered Design: Inclusive and equitable outcomes are considered in the design, implementation, and internal operations of the solution.
  • Scalability: The solution has a plan for equitable viability and the potential to be scaled to affect the lives of more people in low- and middle-income countries.
  • Proximate Leadership: The solution is led by a visionary entrepreneur, innovator, or team who has deep understanding of the communities they serve and the problem they are trying to solve, expertise to develop and implement solutions, and the ability to adapt and respond to fe
  • Technical Feasibility: The applicant has provided convincing evidence that the data/analytics underpinning the solution have been built and function as they claim they do, even if only proof-of-concept.

Solutions

Selected

AMRoots: AMR in small-scale farming communities

By Helen McIlleron
Helen McIlleron Tasha Koch Mary-Ann Davies Craig Kinnear Rachel Wynberg Lubbe Wiesner
Selected

AMRSense: Empowering Communities with a Proactive OneHealth Ecosystem

By Tavpritesh Sethi
Tavpritesh Sethi Nikhil Doegar Harpreet Singh Tikesh Bisen Kritika Gupta
Selected

OASIS: OneHealth Antimicrobial Stewardship for Informal Health Systems

By Meenakshi Gautham
Meenakshi Gautham Sujay Santra Chang Ho Yoon Indranil Samanta Kathryn Holt Sanghita Bhattacharyya Catherine Goodman Priya Balasubramaniam
Selected

Farm2Vet: Combatting AMR on the Farm Frontier

By Giang Phi
Giang Phi Helen Nguyen Kok-Seng Wong Khoa D. Doan
Finalist

SafeMeat

By Grace Chitau
Grace Chitau
Finalist

CHAMP: Community Health Antimicrobial Resistance Platform

By Pranav Savanur
Pranav Savanur Ruchit Nagar Mohammad Sarfarazul Ambiya Mohammed Shahnawaz Hemant Sharma
Finalist

Community Surveillance and AI Solutions for AMR Reduction in Kenya

By Abdullah Kanneh
Abdullah  Kanneh
Finalist

AMR in urban informal settlements of Fiji: insights for policy action

By Brett Davis
Brett Davis
Submitted

Deciphering the nexus of AMR in One Health using Digital Innovation

By Emily Sheldon
Emily Sheldon Harry Akligoh Samuel Sakyi Alexander Kwakye
Submitted

1Mpacto AZap: AI-Driven Antimicrobial Resistance Mapping in Brazil

By João Marcelo Occhiucci
João Marcelo Occhiucci David Souza Jose Belizario Vanessa Lima Souza Vilar Humberto Garay-Malpartida
Submitted

CitiSafe

By Nyamizi Maganga
Nyamizi Maganga
Submitted

VetCare360: Advancing Antimicrobial Resistance Solutions

By RITHA PASKALI
RITHA PASKALI
Submitted

AMR Alert System for real-time surveillance of AMR (AMR ALS Thailand)

By Pimlapas Leekitcharoenphon
Pimlapas Leekitcharoenphon Thidathip Wongsurawat Piroon Jenjaroenpun Achiraya Siriphap Nuvee Prapasarakul
Submitted

Equitable AI use to reduce the impact of AMR and bacterial infections

By Geraldine Mbagwu
Geraldine Mbagwu
Submitted

Saving lives by optimizing the MDA vs AMR tradeoff

By Seth Blumberg
Seth Blumberg Sani OUSMANE Thumbi Mwangi Ashley Styczynski Thuy Doan Gwen Knight Thomas Lietman Kieran O'Brien

Co-chairs

Mark Dybul

Mark Dybul

Center for Global Health Practice and Impact, Georgetown University Medical Center, Professor of Medicine, Chief Strategy Officer
Dr. Divleen Jeji

Dr. Divleen Jeji

Google, India Lead, Google Health

Judges

Patipat Susumpow

Patipat Susumpow

Opendream, Managing Director
Mark Dybul

Mark Dybul

Center for Global Health Practice and Impact, Georgetown University Medical Center, Professor of Medicine, Chief Strategy Officer
Dr. Divleen Jeji

Dr. Divleen Jeji

Google, India Lead, Google Health
Kat Esser

Kat Esser

Amazon, Principal, Health Equity Strategy & Innovation
Mirfin Mpundu

Mirfin Mpundu

ReAct Africa, Executive Director
Lesley-Anne  Long

Lesley-Anne Long

Wonderfuture, CEO
Karen  Bett

Karen Bett

Global Partnership for Sustainable Development Data, Senior Policy Manager, Data Equity & Inclusion
Peiling  Yap

Peiling Yap

HealthAI - The Global Agency for Responsible AI in Health, Chief Scientist
Erick  Venant

Erick Venant

Roll Back Antimicrobial Resistance Initiative(RBA Initiative)
Akhil  Bansal

Akhil Bansal

AMR Funding Circle, Founder
Sumi  Robson

Sumi Robson

Wellcome Trust, Senior Research Manager
Metuge  Alain

Metuge Alain

Reach Out Cameroon, Head of Health Department
Yewande  Alimi

Yewande Alimi

Africa CDC, One Health Unit Lead
Aqil  Jeenah

Aqil Jeenah

McKinsey & Company, Management Consultant | Veterinarian
Dr. Christopher Butler

Dr. Christopher Butler

Elizabeth  Ashley

Elizabeth Ashley

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Director
Glenda Gray

Glenda Gray

South African Medical Research Council, President and CEO
James Anderson

James Anderson

IFPMA, Executive Director, Global Health
Timothy Walsh

Timothy Walsh

Ineos Oxford Institute, Microbiologist
Dr. Toby Leslie

Dr. Toby Leslie